ALK-tyrosine kinase inhibitor intrinsic resistance due to de novo MET-amplification in metastatic ALK-rearranged non-small cell lung cancer effectively treated by alectinib-crizotinib combination-case report.
Saved in:
| Title: | ALK-tyrosine kinase inhibitor intrinsic resistance due to de novo MET-amplification in metastatic ALK-rearranged non-small cell lung cancer effectively treated by alectinib-crizotinib combination-case report. |
|---|---|
| Authors: | Urbanska EM; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Grauslund M; Department of Pathology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Berger SMS; Department of Radiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Costa JC; Department of Radiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Koffeldt PR; Department of Pathology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Sørensen JB; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Santoni-Rugiu E; Department of Pathology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. |
| Source: | Translational lung cancer research [Transl Lung Cancer Res] 2024 Sep 30; Vol. 13 (9), pp. 2453-2462. Date of Electronic Publication: 2024 Sep 26. |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Pioneer Bioscience Publishing Company Country of Publication: China NLM ID: 101646875 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2218-6751 (Print) Linking ISSN: 22186751 NLM ISO Abbreviation: Transl Lung Cancer Res Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39430327 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: ALK-tyrosine kinase inhibitor intrinsic resistance due to de novo MET-amplification in metastatic ALK-rearranged non-small cell lung cancer effectively treated by alectinib-crizotinib combination-case report. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Urbanska+EM%22">Urbanska EM</searchLink>; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Grauslund+M%22">Grauslund M</searchLink>; Department of Pathology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Berger+SMS%22">Berger SMS</searchLink>; Department of Radiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Costa+JC%22">Costa JC</searchLink>; Department of Radiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Koffeldt+PR%22">Koffeldt PR</searchLink>; Department of Pathology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Sørensen+JB%22">Sørensen JB</searchLink>; Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Santoni-Rugiu+E%22">Santoni-Rugiu E</searchLink>; Department of Pathology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101646875%22">Translational lung cancer research</searchLink> [Transl Lung Cancer Res] 2024 Sep 30; Vol. 13 (9), pp. 2453-2462. <i>Date of Electronic Publication: </i>2024 Sep 26. – Name: TypePub Label: Publication Type Group: TypPub Data: Case Reports; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Pioneer+Bioscience+Publishing+Company%22">Pioneer Bioscience Publishing Company </searchLink><i>Country of Publication: </i>China <i>NLM ID: </i>101646875 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2218-6751 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222186751%22">22186751 </searchLink><i>NLM ISO Abbreviation: </i>Transl Lung Cancer Res <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39430327 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.21037/tlcr-24-439 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2453 Titles: – TitleFull: ALK-tyrosine kinase inhibitor intrinsic resistance due to de novo MET-amplification in metastatic ALK-rearranged non-small cell lung cancer effectively treated by alectinib-crizotinib combination-case report. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Urbanska EM – PersonEntity: Name: NameFull: Grauslund M – PersonEntity: Name: NameFull: Berger SMS – PersonEntity: Name: NameFull: Costa JC – PersonEntity: Name: NameFull: Koffeldt PR – PersonEntity: Name: NameFull: Sørensen JB – PersonEntity: Name: NameFull: Santoni-Rugiu E IsPartOfRelationships: – BibEntity: Dates: – D: 30 M: 09 Text: 2024 Sep 30 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 2218-6751 Numbering: – Type: volume Value: 13 – Type: issue Value: 9 Titles: – TitleFull: Translational lung cancer research Type: main |
| ResultId | 1 |
